Matti L. Gild

1.3k citations
53 papers · 824 indexed · h-index 16

Matti L. Gild

47 papers receiving 812 citations

Peers

Matti L. Gild
Comparison fields: 5 of 66
  • Endocrinology, Diabetes and Metabolism 511
  • Health Informatics 15
  • Oncology 254
  • Cancer Research 101
  • Radiology, Nuclear Medicine and Imaging 89
Replace Ronald A. Ghossein with:
Ronald A. Ghossein United States
Ning Qu China
Venessa Tsang Australia
Todd Riehl United States
Chuanming Zheng China
Priyanka Iyer United States
Stephen Raskin Israel
Daria Arbogast United States
Agnese Biagini Italy
Jiachao Liang United States
Matti L. Gild relative to Ronald A. Ghossein United States Ronald A. Ghossein's profile →
Citations per field
00.5×3.8×
Ronald A. Ghossein · 1×
Citations per year

Countries citing papers authored by Matti L. Gild

Since Specialization
Citations

This map shows the geographic impact of Matti L. Gild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti L. Gild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti L. Gild more than expected).

Fields of papers citing papers by Matti L. Gild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti L. Gild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti L. Gild. The network helps show where Matti L. Gild may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matti L. Gild, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matti L. Gild Line = papers co-authored together Matti L. Gild links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20250
4 20253
5 20242
6 202411
7 20231
8 20233
9 20235
10 202337
11 20233
12 20231
13 20225
14 20210
15 202157
16 201924
17 20176
18 20156
19 2013116
20 2011110

About Matti L. Gild

Matti L. Gild is a scholar working on Endocrinology, Diabetes and Metabolism, Anatomy and Oncology, having authored 53 papers that have together received 824 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (32 papers), Pituitary Gland Disorders and Treatments (9 papers), Thyroid and Parathyroid Surgery (8 papers), Cancer-related Molecular Pathways (6 papers), Neuroendocrine Tumor Research Advances (6 papers), BRCA gene mutations in cancer (4 papers), Thyroid Disorders and Treatments (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (511 citations), Health Informatics (15 citations) and Oncology (254 citations). Matti L. Gild has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Roderick Clifton‐Bligh, Bruce G. Robinson, Venessa Tsang, Martyn Bullock, Mabel Ryder, Jeffrey A. Knauf, Ronald Ghossein, James A. Fagin, Eric G. Pamer and Johanna A. Joyce. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026